Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 220

1.

A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1.

Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Khizer SH, Chatterjee G, Tembhare P, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Khattry N, Bagal B, Sengar M, Gujral S, Subramanian P.

Blood Cancer J. 2019 Oct 1;9(10):79. doi: 10.1038/s41408-019-0244-2. No abstract available.

2.

Surgical Skills Workshops Should Be a Part of the United Kingdom Undergraduate Medical Curriculum.

Hakim MA, Dominguez ED, Priest S, Lee KS, Mardanpour A, Tandle S, Al-Khalil M, Slade G, Gujral S.

Cureus. 2019 May 11;11(5):e4642. doi: 10.7759/cureus.4642.

3.

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World Context.

Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Deshpande N, Kadechkar S, Chatterjee G, Kannan S, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Khizer SH, Khattry N, Tembhare P, Gujral S, Subramanian P.

Front Oncol. 2019 Jun 13;9:450. doi: 10.3389/fonc.2019.00450. eCollection 2019.

4.

A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients.

Tembhare PR, Subramanian Pg PG, Ghogale S, Chatterjee G, Patkar NV, Gupta A, Shukla R, Badrinath Y, Deshpande N, Narula G, Rodrigues P, Girase K, Dhaliwal D, Prasad M, Shetty D, Banavali S, Gujral S.

Cytometry B Clin Cytom. 2019 Jun 14. doi: 10.1002/cyto.b.21831. [Epub ahead of print]

PMID:
31197916
5.

Technology-assisted cognitive-behavioral therapy intervention for end-stage renal disease.

Jakubowski KP, Jhamb M, Yabes J, Gujral S, Oberlin LE, Bender FH, Steel JL.

Transl Behav Med. 2019 May 27. pii: ibz077. doi: 10.1093/tbm/ibz077. [Epub ahead of print]

PMID:
31131853
6.

Management of Vulval Lichen Sclerosus-The Role of the Plastic Surgeon.

Gujral S, Coelho J, Chummun S, Watts A.

Eplasty. 2019 Apr 24;19:ic12. eCollection 2019. No abstract available.

7.

Exercise for Depression: A Feasibility Trial Exploring Neural Mechanisms.

Gujral S, Aizenstein H, Reynolds CF 3rd, Butters MA, Grove G, Karp JF, Erickson KI.

Am J Geriatr Psychiatry. 2019 Jun;27(6):611-616. doi: 10.1016/j.jagp.2019.01.012. Epub 2019 Jan 17.

PMID:
30797651
8.

Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.

Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S.

Oncotarget. 2019 Jan 15;10(5):617. doi: 10.18632/oncotarget.26610. eCollection 2019 Jan 15.

9.

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.

Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S.

Oncotarget. 2018 Nov 27;9(93):36613-36624. doi: 10.18632/oncotarget.26400. eCollection 2018 Nov 27. Erratum in: Oncotarget. 2019 Jan 15;10(5):617.

10.

BRAFV600E mutation in hairy cell leukemia: A single-center experience.

Bibi A, Java S, Chaudhary S, Joshi S, Mascerhenas R, Rabade N, Tembhare P, Subramanian PG, Gujral S, Menon H, Khattry N, Sengar M, Bagal B, Jain H, Patkar N.

Indian J Pathol Microbiol. 2018 Oct-Dec;61(4):532-536. doi: 10.4103/IJPM.IJPM_484_16.

11.

Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.

Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian PG, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable N, Deodhar J, Jadhav S, Pawaskar P, Mathew L, Menon H, Nair R, Kannan S, Chiplunkar S, Gujral S.

Indian J Cancer. 2018 Jan-Mar;55(1):9-15. doi: 10.4103/ijc.IJC_656_17.

12.

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.

Nair R, Kakroo A, Bapna A, Gogia A, Vora A, Pathak A, Korula A, Chakrapani A, Doval D, Prakash G, Biswas G, Menon H, Bhattacharya M, Chandy M, Parihar M, Vamshi Krishna M, Arora N, Gadhyalpatil N, Malhotra P, Narayanan P, Nair R, Basu R, Shah S, Bhave S, Bondarde S, Bhartiya S, Nityanand S, Gujral S, Tilak TVS, Radhakrishnan V.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):398-421. doi: 10.1007/s12288-018-0991-4. Epub 2018 Aug 3. Review.

13.

Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.

Narula G, Prasad M, Jatia S, Subramanian PG, Patkar N, Tembhare P, Shetty D, Khanna N, Laskar S, Shet T, Epari S, Kembhavi S, Shah S, Qureshi S, Gujral S, Banavali SD.

Indian J Cancer. 2017 Oct-Dec;54(4):609-615. doi: 10.4103/ijc.IJC_487_17.

14.
15.

An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.

Verma A, Epari S, Gujral S, Shet T.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):271-274. doi: 10.4103/IJPM.IJPM_194_17.

16.

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.

Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):209-213. doi: 10.4103/IJPM.IJPM_223_17.

17.

Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences.

Modkharkar S, Navale P, Amare PK, Chougule A, Patkar N, Tembhare P, Menon H, Sengar M, Khattry N, Banavali S, Arora B, Narula G, Laskar S, Khanna N, Muckaden MA, Rangarajan V, Agrawal A, Shet T, Epari S, Subramanian PG, Gujral S.

Indian J Pathol Microbiol. 2018 Jan-Mar;61(1):58-65. doi: 10.4103/IJPM.IJPM_56_17.

18.

Cutaneous Pyoderma Gangrenosum of the Hand.

Mihailidis T, Izadi D, Gujral S.

Eplasty. 2018 Feb 5;18:ic4. eCollection 2018. No abstract available.

19.

Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.

Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S, Tembhare P, Hasan SK, Jain H, Sengar M, Narula G, Banavali S, Kadam PA, Shetty D, Gujral S, Patkar N.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018002. doi: 10.4084/MJHID.2018.002. eCollection 2018.

20.

Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.

Agrawal K, Shet T, Sridhar E, Dhende S, Sengar M, Arora B, Laskar S, Gujral S, Menon H, Banavali S.

Indian J Pathol Microbiol. 2017 Oct-Dec;60(4):533-540. doi: 10.4103/IJPM.IJPM_778_15.

Supplemental Content

Loading ...
Support Center